Skip to content

Defining, and then watching for, treatment failure

EACS: Switching to atazanavir maintains viral suppression, even in patients with protease resistance

EACS: Nevirapine studies highlight new first-line uses

EACS: Old campaigners: Belgians document long-term AIDS survival

EACS: Kaletra monotherapy may need excellent adherence to work

EACS: Growth-hormone drug reduces abdominal fat – if you keep on taking it

EACS: CD4 cells: the lower you start, the lower you finish

EACS: Drugs that get into the brain work better for neurological AIDS diseases

EACS proposes list of ‘indicator diseases’ to prompt the offer of an HIV test